Skip to main content
SpringerLink
Log in

Cancer screening guidelines and prevention factors for high-risk patients with a family history of colorectal cancer

  • Published:
Current Colorectal Cancer Reports

Abstract

Family history of colorectal cancer or of adenomas may confer significant risk of colorectal cancer. Ideally, diagnosis of an inherited syndrome such as familial adenomatous polyposis (FAP) or hereditary nonpolyposis colorectal cancer (HNPCC) enables a molecular biology-driven approach to screening and management. When no hereditary syndrome can be established, clinicians must rely on empiric risk estimates and offer screening accordingly. Detailed rationale and guidelines for use of syndrome characteristics including genetic testing, counseling, and selection of surveillance tools are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Cummings JH, Bingham SA: Diet and the prevention of cancer. BMJ 1998, 317:1636–1640.

    PubMed  CAS  Google Scholar 

  2. US Preventive Services Task Force: Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force, edn 2. Baltimore: Williams & Wilkins; 1996.

    Google Scholar 

  3. Tomeo CA, Colditz GA, Willett WC, et al.: Harvard report on cancer prevention, vol 3: prevention of colon cancer in the United States. Cancer Causes Control 1999, 10:167–180.

    Article  PubMed  CAS  Google Scholar 

  4. Smith RA, Cokkinides V, Eyre HJ: American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2005, 55:31–44.

    Article  PubMed  Google Scholar 

  5. Selby JV, Friedman GD, Quesenberry CP Jr, et al.: A casecontrol study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992, 326:653–657.

    Article  PubMed  CAS  Google Scholar 

  6. Newcomb PA, Norfleet RG, Storer BE, et al.: Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992, 84:1572–1575.

    Article  PubMed  CAS  Google Scholar 

  7. Berry DP, Clarke P, Hardcastle JD, Vellacott KD: Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Br J Surg 1997, 84:1274–1276.

    Article  PubMed  CAS  Google Scholar 

  8. Vernon S: Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997, 89:1406–1422.

    Article  PubMed  CAS  Google Scholar 

  9. Lieberman DA, Weiss DG, Bond JH, et al.: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000, 343:162–168.

    Article  PubMed  CAS  Google Scholar 

  10. Winawer S, Fletcher R, Rex D, et al.: Colorectal cancer screening and surveillance: clinical guidelines and rationale- Update based on new evidence. Gastroenterology 2003, 124:544–560.

    Article  PubMed  Google Scholar 

  11. Groden J, Thliveris A, Samowitz W, et al.: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66:589–600.

    Article  PubMed  CAS  Google Scholar 

  12. Kinzler KW, Nilbert MC, Su LK, et al.: Identification of FAP locus genes from chromosome 5q21. Science 1991, 253:661–665.

    Article  PubMed  CAS  Google Scholar 

  13. Giardiello FM, Brensinger JD, Tersmette AC, et al.: Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000, 119:1447–1453.

    Article  PubMed  CAS  Google Scholar 

  14. Howe JR, Mitros FA, Summers RW: The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol 1995, 5:751–756.

    Article  Google Scholar 

  15. Rashid A, Houlihan PS, Booker S, et al.: Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000, 119:323–332.

    Article  PubMed  CAS  Google Scholar 

  16. Leppert M, Burt R, Hughes JP, et al.: Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med 1990, 322:904–908.

    Article  PubMed  CAS  Google Scholar 

  17. Spirio L, Olschwang S, Groden J, et al.: Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993, 75:951–957.

    Article  PubMed  CAS  Google Scholar 

  18. Al-Tassan N, Chmiel NH, Maynard J, et al.: Inherited variants of MYH associated with somatic G:C--> T:A mutations in colorectal tumors. Nat Genet 2002, 30:227–232.

    Article  PubMed  CAS  Google Scholar 

  19. Berk T, Cohen Z, Bapat B, et al.: Negative genetic test result in familial adenomatous polyposis: clinical screening implications. Dis Colon Rectum 1999, 42:307–310; discussion 310-312.

    Article  PubMed  CAS  Google Scholar 

  20. Petersen GM, Slack J, Nakamura Y: Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 1991, 100:1658–1664.

    PubMed  CAS  Google Scholar 

  21. Bülow S, Bülow C, Nielsen TF, et al.: Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register. Scand J Gastroenterol 1995, 30:989–993.

    PubMed  Google Scholar 

  22. Church J, Burke C, McGannon E, et al.: Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options. Dis Colon Rectum 2003, 46:1175–1181.

    Article  PubMed  Google Scholar 

  23. Bülow S, Björk J, Christensen IJ, et al.: Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004, 53:381–386.

    Article  PubMed  Google Scholar 

  24. Hawk E, Umar A, Viner JL: Colorectal cancer chemoprevention —an overview of the science. Gastroenterology 2004, 126:1423–1447.

    Article  PubMed  Google Scholar 

  25. Vasen HF, Offerhaus GJ, den Hartog Jager FC, et al.: The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands. Int J Cancer 1990, 46:31–34.

    Article  PubMed  CAS  Google Scholar 

  26. Aarnio M, Mecklin JP, Aaltonen LA, et al.: Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995, 64:430–433.

    Article  PubMed  CAS  Google Scholar 

  27. Watson P, Vasen HF, Mecklin JP, et al.: The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 1994, 96:516–520.

    Article  PubMed  CAS  Google Scholar 

  28. Hamilton SR, Liu B, Parsons RE, et al.: The molecular basis of Turcot’s syndrome. N Engl J Med 1995, 332:839–847.

    Article  PubMed  CAS  Google Scholar 

  29. Lynch HT, Lynch PM, Pester J, et al.: The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre’s syndrome. Arch Intern Med 1981, 141:607–611.

    Article  PubMed  CAS  Google Scholar 

  30. Vasen HF, Mecklin JP, Khan PM, et al.: The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991, 34:424–425.

    Article  PubMed  CAS  Google Scholar 

  31. Vasen HF, Watson P, Mecklin JP, et al.: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999, 116:1453–1456.

    Article  PubMed  CAS  Google Scholar 

  32. Cao Y, Pieretti M, Marshall J, et al.: Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature. Am J Gastroenterol 2002, 97:1822–1827.

    Article  PubMed  Google Scholar 

  33. Aaltonen LA, Salovaara R, Kristo P, et al.: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998, 338:1481–1487.

    Article  PubMed  CAS  Google Scholar 

  34. Peltomaki P, Aaltonen LA, Sistonen P, et al.: Genetic mapping of a locus predisposing to human coorectal cancer. Science 1993, 260:810–812.

    Article  PubMed  CAS  Google Scholar 

  35. Leach FS, Nicolaides NC, Papadopoulos N, et al.: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993, 75:1215–1225.

    Article  PubMed  CAS  Google Scholar 

  36. Marra G, Boland CR: Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995, 87:1114–1125.

    Article  PubMed  CAS  Google Scholar 

  37. Papadopoulos N, Nicolaides NC, Wei YF, et al.: Mutation of a mutL homolog in hereditary colon cancer. Science 1994, 263:1625–1629.

    Article  PubMed  CAS  Google Scholar 

  38. Miyaki M, Konishi M, Tanaka K, et al.: Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997, 17:271–2.

    Article  PubMed  CAS  Google Scholar 

  39. Nicolaides NC, Papadopoulos N, Liu B, et al.: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994, 371:75–80.

    Article  PubMed  CAS  Google Scholar 

  40. Aaltonen LA, Peltomäki P, Leach FS, et al.: Clues to the pathogenesis of familial colorectal cancer. Science 1993, 260:812–816.

    Article  PubMed  CAS  Google Scholar 

  41. Umar A, Boland CR, Terdiman JP, et al.: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004, 96:261–268.

    Article  PubMed  CAS  Google Scholar 

  42. Thibodeau SN, French AJ, Roche PC, et al.: Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996, 56:4836–4340.

    PubMed  CAS  Google Scholar 

  43. Lindor NM, Burgart LJ, Leontovich O, et al.: Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002, 20:1043–1048.

    Article  PubMed  CAS  Google Scholar 

  44. Jass JR, Stewart SJ, Lane MR: Hereditary non-polyposis colorectal cancer -morphologies, genes and mutations. Mutation Research 1994, 310:125–133.

    PubMed  CAS  Google Scholar 

  45. Syngal S, Fox EA, Li C, et al.: Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA 1999, 282:247–253.

    Article  PubMed  CAS  Google Scholar 

  46. American Society of Human Genetics: ASHG Statement: professional disclosure of familial genetic information. Am J Hum Genet 1999, 62:474–483.

    Article  Google Scholar 

  47. Gritz ER, Peterson SK, Vernon SW, et al.: Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005, 23:1902–1910.

    Article  PubMed  Google Scholar 

  48. Wang Y, Friedl W, Lamberti C, et al.: Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Int J Cancer 2003, 103:636–641.

    Article  PubMed  CAS  Google Scholar 

  49. Järvinen HJ, Aarnio M, Mustonen H, et al.: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000, 118:829–834.

    Article  PubMed  Google Scholar 

  50. Burke W, Petersen G, Lynch P, et al.: Recommendations for follow- up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997, 277:915–919.

    Article  PubMed  CAS  Google Scholar 

  51. Vasen HF, den Hartog Jager FC, Menko FH, et al.: Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands. Am J Med 1989, 86:278–281.

    Article  PubMed  CAS  Google Scholar 

  52. Rijcken FEM, Hollema H, Kleibeuker JH: Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 2002, 50:382–386.

    Article  PubMed  CAS  Google Scholar 

  53. Kiesslich R, Jung M, DiSario JA, Galle PR, Neurath MF: Perspectives of chromo and magnifying endoscopy: how, how much, when, and whom should we stain. Clin Gastro 2004, 38:7–13.

    Article  CAS  Google Scholar 

  54. De Jong AE, Morreau H, Van Puijenbroek M, et al.: The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 2004, 126:42–48.

    Article  PubMed  CAS  Google Scholar 

  55. Winawer SJ, Zauber AG, Ho MN, et al.: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993, 329:1977–1981.

    Article  PubMed  CAS  Google Scholar 

  56. Citarda F, Tomaselli G, Capocaccia R, et al.: Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001, 48:812–815.

    Article  PubMed  CAS  Google Scholar 

  57. Ahmad NA, Kochman ML, Long WB, et al.: Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest Endosc 2002, 55:390–396.

    Article  PubMed  Google Scholar 

  58. Fuchs CS, Giovannucci EL, Colditz GA, et al.: A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994, 331:1669–1674.

    Article  PubMed  CAS  Google Scholar 

  59. Winawer SJ, Zauber AG, Gerdes H, et al.: Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996, 334:82–87.

    Article  PubMed  CAS  Google Scholar 

  60. NCCN Clinical Practice Guidelines In Oncology. http://www.nccn.org/professionals/physician_gls/default.asp This is a current detailed algorithm for evaluation and screening of patients with FAP, HNPCC, and a positive family history.

  61. PDQ - NCI’s Comprehensive Cancer Database, Genetics Summaries Of Colorectal Cancer. http://www.cancer.gov/ cancertopics/pdq/cancerdatabase This is a current comprehensive evidence-based review of literature on FAP, HNPCC, and familial colon cancer.

Download references

Author information

Authors and Affiliations

  1. Department of Gastrointestinal Medicine and Nutrition-436, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, 77030, Houston, TX, USA

    Patrick M. Lynch JD, MD

Authors
  1. Patrick M. Lynch JD, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lynch, P.M. Cancer screening guidelines and prevention factors for high-risk patients with a family history of colorectal cancer. Curr colorectal cancer rep 1, 110–116 (2005). https://doi.org/10.1007/s11888-005-0007-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11888-005-0007-2

Keywords

Search

Navigation